|
PIK3CA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.977600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.761580E-02 |
| Normal-vs-Stage2 |
1.975690E-03 |
| Normal-vs-Stage3 |
5.120700E-03 |
| Normal-vs-Stage4 |
4.381600E-02 |
| Stage1-vs-Stage2 |
1.286600E-01 |
| Stage1-vs-Stage3 |
3.111400E-01 |
| Stage1-vs-Stage4 |
7.620400E-01 |
| Stage2-vs-Stage3 |
4.482000E-01 |
| Stage2-vs-Stage4 |
3.128400E-01 |
| Stage3-vs-Stage4 |
6.639800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.265700E-02 |
| Normal-vs-AfricanAmerican |
4.764200E-01 |
| Normal-vs-Asian |
4.935600E-02 |
| Caucasian-vs-AfricanAmerican |
4.030000E-01 |
| Caucasian-vs-Asian |
9.540200E-01 |
| AfricanAmerican-vs-Asian |
4.398600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.430300E-04 |
| Normal-vs-Female |
1.254240E-02 |
| Male-vs-Female |
8.398100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.332570E-01 |
| Normal-vs-Age(41-60Yrs) |
2.356300E-03 |
| Normal-vs-Age(61-80Yrs) |
2.575900E-03 |
| Normal-vs-Age(81-100Yrs) |
2.959800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.100300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.791500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.307800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.091600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.002200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.110000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.244000E-01 |
| Classical-VS-Follicular |
8.27030000039031E-07 |
| Classical-VS-Other |
1.226160E-01 |
| Classical-VS-Normal |
1.568200E-01 |
| Tall-VS-Follicular |
3.839900E-03 |
| Tall-VS-Other |
1.204560E-01 |
| Tall-VS-Normal |
1.931160E-01 |
| Follicular-VS-Other |
9.710400E-01 |
| Follicular-VS-Normal |
3.60250000053242E-07 |
| Other-VS-Normal |
1.804000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.575190E-04 |
| Normal-vs-N1 |
4.864200E-02 |
| N0-vs-N1 |
2.398200E-01 |
|
|
